Brian Ritchie

Head of Investor Relations

Equibles does not estimate personal net worth.

Get an email with a short summary when Elicio Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get ELTX alerts

About Brian Ritchie

Brian Ritchie is recorded as Head of Investor Relations at Elicio Therapeutics, Inc. (ELTX). Brian Ritchie has spoken on 1 investor event across 1 company, most recently for Elicio Therapeutics, Inc. on June 15, 2026. Elicio Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Elicio Therapeutics, Inc. includes Robert Connelly (CEO, Chief Accounting Officer and Board Member), Julian Adams (Chairman), Julian Adams, Ph.D. (Chairman and Board Member) and 7 others.

Brian Ritchie on recent calls

“Good morning, everyone, and welcome to a Lissing Out Therapeutics conference call to discuss results from the Phase II Amplify 7P study and the path forward for ELI 002 7P in adjuvant mutant KRAS-driven pancreatic cancer.”

Head of Investor Relations, June 15th Conference Call · June 15, 2026

Affiliation history

Elicio Therapeutics, Inc. (ELTX)
Head of Investor Relations

Transcript header (unverified)

Current

Company network

Elicio Therapeutics, Inc.

ELTX

Current role

Biotechnology · Healthcare

Head of Investor Relations

1 appearance Latest appearance 2026-06-15

View calls and events

Leadership on record at Elicio Therapeutics, Inc.

Robert Connelly CEO, Chief Accounting Officer, Board Member
Julian Adams Chairman
Julian Adams, Ph.D. Chairman, Board Member
Brian Piekos CFO
Preetam Shah, Ph.D., M.B.A. CFO, Chief Accounting Officer
Jennifer J. Rhodes General Counsel
Allen R. Nissenson Board Member
Allen R. Nissenson, M.D. Board Member
Assaf Segal Board Member
Carol Ashe Board Member

Recent activity

Conference June 15th Conference Call Elicio Therapeutics, Inc. (ELTX)
2026-06-15